title: Microsatellite DNA analysis does not distinguish malignant from benign pleural effusions.
abstract: Distinguishing malignant from benign pleural effusions using routine cytology is a common diagnostic problem. Recently, genetic alterations, including microsatellite instability (MSI) and loss of heterozygosity (LOH), have been described in malignant pleural effusions and proposed as methods improving diagnostics. The purpose of this study was to evaluate a panel of molecular markers for the detection of genetic alterations of cells in pleural effusions and to determine their diagnostic value as an additional test to cytologic examination. Pleural fluid and peripheral blood from 48 patients (36 male and 12 female, median age 71 years) were analyzed. Twenty-six patients had malignant pleural effusion, including 23 lung cancer and three metastatic non-pulmonary carcinoma. The control group consisted of 22 patients with benign pleural effusions. Only 14 malignancy-associated pleural effusions were cytology-positive for malignant cells (54%), whereas all benign pleural effusions were negative. DNA was extracted from all the samples and analysed for MSI and/or LOH using the following microsatellite markers: D3S1234, D9S171, D12S363, D17S250, D5S346 and TP53Alu, located at five chromosomal regions: 3p, 9p, 12q, 17q, 5q. Microsatellite analysis of the pleural fluid pellet exhibited genetic alterations in two neoplastic pleural fluid cases and in one inflammatory case. Two out of 26 (7.6%) patients with malignant pleural effusion showed genetic alterations. One exhibited MSI in three different microsatellite markers (D17S250, D9S171, D3S134) and the other showed LOH in marker D3S134. One out of 22 (4.5%) patients with benign pleural effusion showed LOH in marker D3S134. In conclusion, genetic alterations at the level of microsatellite DNA, were detected only in very few cases of malignant pleural effusions, and in one case of benign pleural effusion. Thus, our data suggest that microsatellite DNA analysis does not facilitate the diagnosis of malignant pleural effusion.
authors.affiliation: Department of Thoracic Medicine, University Hospital, Medical School, University of Crete, Heraklion 71110, Greece.
authors.forename: F
authors.initials: F
authors.lastname: Economidou
authors.forename: E G
authors.initials: EG
authors.lastname: Tzortzaki
authors.forename: S
authors.initials: S
authors.lastname: Schiza
authors.forename: K M
authors.initials: KM
authors.lastname: Antoniou
authors.forename: E
authors.initials: E
authors.lastname: Neofytou
authors.forename: M
authors.initials: M
authors.lastname: Zervou
authors.forename: I
authors.initials: I
authors.lastname: Lambiri
authors.forename: N M
authors.initials: NM
authors.lastname: Siafakas
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D002874:Chromosome Mapping; D002877:Chromosomes, Human; D004247:DNA / Q000235:genetics*; D004273:DNA, Neoplasm / Q000235:genetics*; D005260:Female; D042822:Genomic Instability; D006801:Humans; D007770:L-Lactate Dehydrogenase / Q000032:analysis; D008297:Male; D018895:Microsatellite Repeats; D008875:Middle Aged; D009363:Neoplasm Proteins / Q000032:analysis; D010996:Pleural Effusion / Q000503:physiopathology*; D010997:Pleural Neoplasms / Q000503:physiopathology*; D011506:Proteins / Q000032:analysis
chemical_list: D004273:DNA, Neoplasm; D009363:Neoplasm Proteins; D011506:Proteins; D004247:DNA; D007770:L-Lactate Dehydrogenase